Consumption Externality and Yield Uncertainty in the Influenza Vaccine Supply Chain: Interventions in Demand and Supply Sides

Published Online:https://doi.org/10.1287/mnsc.1110.1469

References

  • Amaldoss W., Jain S. Conspicuous consumption and sophisticated thinking. Management Sci. (2005) 51(10):1449–1466LinkGoogle Scholar
  • Arifoğlu K., Deo S., Iravani S. Coordinating supply chains with uncertain yield and consumption externalities. (2011) . Working paper, Northwestern University, Evanston, ILGoogle Scholar
  • Aumann R. J. Markets with a continuum of traders. Econometrica (1964) 32(1/2):39–50CrossrefGoogle Scholar
  • Bauch C. T., Earn D. J. D. Vaccination and the theory of games. Proc. Natl. Acad. Sci. USA (2004) 101(36):13391–13394CrossrefGoogle Scholar
  • Breban R., Vardavas R., Blower S. Mean-field analysis of an inductive reasoning game: Application to influenza vaccination. Physical Rev. E (2007) 76(3):031127-1–031127-11CrossrefGoogle Scholar
  • Brito D. L., Sheshinski E., Intriligator M. D. Externalities and compulsory vaccinations. J. Public Econom. (1991) 45(1):69–90CrossrefGoogle Scholar
  • Cachon G. P., Swinney R. Purchasing, pricing, and quick response in the presence of strategic consumers. Management Sci. (2009) 55(3):497–511LinkGoogle Scholar
  • Centers for Disease Control and Prevention (CDC) Vaccine price list. (2009) . http://www.cdc.gov/vaccines/programs/vfc/cdc-vac-price-list.htmGoogle Scholar
  • Chapman G. B., Coups E. J. Predictors of influenza vaccine acceptance among healthy adults. Preventive Medicine (1999) 29(4):249–262CrossrefGoogle Scholar
  • Chick S. E., Mamani H., Simchi-Levi D. Supply chain coordination and influenza vaccination. Oper. Res. (2008) 56(6):1493–1506LinkGoogle Scholar
  • Cho S.-H. The optimal composition of influenza vaccines subject to random production yields. Manufacturing Service Oper. Management (2010) 12(2):256–277LinkGoogle Scholar
  • Dana J. D., Petruzzi N. C. Note: The news vendor model with endogenous demand. Management Sci. (2001) 47(11):1488–1497LinkGoogle Scholar
  • Danzon P. M., Pereira N. S., Tejwani S. S. Vaccine supply: A cross-national perspective. Health Affairs (2005) 24(3):706–717CrossrefGoogle Scholar
  • Deo S., Corbett C. J. Cournot competition under yield uncertainty: The case of the U.S. influenza vaccine market. Manufacturing Service Oper. Management (2009) 11(4):563–576LinkGoogle Scholar
  • Fiore A. E., Uyeki T. M., Broder K., Finelli L., Euler G. L., Singleton J. A., Iskander J. K., Wortley P. M., Shay D. K., Bresee J. S., Cox N. J. Prevention and control of influenza with vaccines: Recommendations of the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report (MMWR) Recommendations and Reports (2010) 59(RR-8):1–62Google Scholar
  • Food and Drug Administration Electronics submission instructions for lot distribution data (eLDD). (2008) . Accessed May 6, 2010, http://www.fda.govGoogle Scholar
  • Gallego G., Şahin Ö. Revenue management with partially refundable fares. Oper. Res. (2010) 58(4, Part 1):817–833LinkGoogle Scholar
  • Galvani A. P., Reluga T. C., Chapman G. B. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc. Natl. Acad. Sci. USA (2007) 104(13):5692–5697CrossrefGoogle Scholar
  • Geoffard P.-Y., Philipson T. Rational epidemics and their public control. Internat. Econom. Rev. (1996) 37(3):603–624CrossrefGoogle Scholar
  • Grady D. With few suppliers of flu shots, shortage was long in making. New York Times (2004) October 17). http://www.nytimes.com/2004/10/17/health/17flu2.htmlGoogle Scholar
  • Harper S. A., Fukuda K., Uyeki T. M., Cox N. J., Bridges C. B. Prevention and control of influenza: Recommendations of the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report (MMWR) Recommendations and Reports (2005) 54(RR-8):1–40Google Scholar
  • Harris G. Ideas and trends; in American health care, drug shortages are chronic. New York Times (2004) October 31). http://query.nytimes.com/gst/fullpage.html?res=9400EFD6103DF932A05753C1A9629C8B63Google Scholar
  • Hartgroves L. C. S. Strategies for influenza vaccines. (2009) . Unpublished doctoral dissertation, Division of Investigative Sciences, Faculty of Medicine, Imperial College London, LondonGoogle Scholar
  • Hill A. N., Longini I. M. The critical fraction for heterogeneous epidemic models. Math. Biosciences (2003) 181(1):85–106CrossrefGoogle Scholar
  • Hinman A. R. Addressing the vaccine financing conundrum: The national vaccine advisory committee weighs in with eight recommendations for more stable vaccine funding. Health Affairs (2005a) 24(3):701–704CrossrefGoogle Scholar
  • Hinman A. R. Financing vaccines in the 21st century: Recommendations from the national vaccine advisory committee. Amer. J. Preventive Medicine (2005b) 29(1):71–75CrossrefGoogle Scholar
  • Hinman A. R., Schwartz H. K., Sloan F. A., Chalk R. A., Giffin R. B. The U.S. vaccine supply. New England J. Medicine (2005) 352(10):1046–1047CrossrefGoogle Scholar
  • Institute of MedicineFinancing Vaccines in the 21st Century: Assuring Access and Availability (2004) (National Academies Press, Washington, DC) Google Scholar
  • Janz N. K., Becker M. H. The health belief model: A decade later. Health Ed. Quart. (1984) 11(1):1–47CrossrefGoogle Scholar
  • Kilbourne E. D. Government should increase flu vaccine role. New York Times (1991) December 11). http://www.nytimes.com/1991/12/11/opinion/1-government-should-increase-flu-vaccine-role-062791.htmlGoogle Scholar
  • Koh W., Paxson D. Blockbuster antivirals and vaccines: Real options in a flu pandemic. (2009) . Working paper, Deutsche Bank AG, SingaporeGoogle Scholar
  • Kornish L. J., Keeney R. L. Repeated commit-or-defer decisions with a deadline: The influenza vaccine composition. Oper. Res. (2008) 56(3):527–541LinkGoogle Scholar
  • Larson E. B., Olsen E., Cole W., Shortell S. The relationship of health benefits and a postcard reminder to influenza vaccination. J. Family Medicine (1979) 8:1207–1211Google Scholar
  • Meltzer M. I., Cox N. J., Fukuda K. The economic impact of pandemic influenza in the United States: Priorities for intervention. Emerging Infectious Diseases (1999) 5(5):659–671CrossrefGoogle Scholar
  • O'Mara D., Fukuda K., Singleton J. A. Influenza vaccine: Ensuring timely and adequate supply. Infections in Medicine (2003) 20:548–554Google Scholar
  • Palese P. Making better influenza virus vaccines? Emerging Infectious Diseases (2006) 12(1):61–65CrossrefGoogle Scholar
  • Pauly M. Improving vaccine supply and development: Who needs what? Health Affairs (2005) 24(3):680–689CrossrefGoogle Scholar
  • Philipson T.Economic Epidemiology and Infectious Diseases (2000) 1(B.V. Elsevier Science, Amsterdam) 1761–1799Chap. 33Google Scholar
  • Reluga T. C., Bauch C. T., Galvani A. P. Evolving public perceptions and stability in vaccine uptake. Math. Biosciences (2006) 204(2):185–198CrossrefGoogle Scholar
  • Sloan F. A., Berman S., Rosenbaum S., Chalk R. A., Giffin R. B. The fragility of the U.S. vaccine supply. New England J. Medicine (2004) 351(23):2443–2447CrossrefGoogle Scholar
  • Su X., Zhang F. Strategic customer behavior, commitment, and supply chain performance. Management Sci. (2008) 54(10):1759–1773LinkGoogle Scholar
  • Tereyağoğlu N., Veeraraghavan S. Selling to conspicuous consumers: Pricing production and sourcing decisions. Management Sci. (2012) . ForthcomingGoogle Scholar
  • U.S. Government Accountability Office (GAO) Flu vaccine: Supply problems heighten need to ensure access for high-risk people. (2001) . Accessed June 1, 2009, http://www.gao.gov/new.items/d01624.pdfGoogle Scholar
  • U.S. Government Accountability Office (GAO) Flu vaccine: Recent supply shortages underscore ongoing challanges. (2004) . Accessed June 1, 2009, http://www.gao.gov/new.items/d05177t.pdfGoogle Scholar
  • U.S. Government Accountability Office (GAO) Influenza vaccine: Issues related to production, distribution and public health messages. (2008) . Accessed June 1, 2009, http://www.gao.gov/new.items/d0827.pdfGoogle Scholar
  • Vietri J. T., Li M., Ibuka Y., Chapman G., Galvani A. Self-interest and altruism in a group vaccination game. (2008) . Working paper, Rutgers University, New Brunswick, NJGoogle Scholar
  • Wall Street Journal Hillary's vaccine shortage. (2003) August 15). http://online.wsj.com/article/0,,SB106091266280731300,00.htmlGoogle Scholar
  • Weycker D., Edelsberg J., Halloran M. E., Longini I. M., Nizam A., Ciuryla V., Oster G. Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 23(10):1284–1293CrossrefGoogle Scholar
  • Wu J. T., Wein L. M., Perelson A. S. Optimization of influenza vaccine selection. Oper. Res. (2005) 53(3):456–476LinkGoogle Scholar
  • Yano C. A., Lee H. L. Lot sizing with random yields: A review. Oper. Res. (1995) 43(2):311–334LinkGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.